This case report illustrates that new blistering during radiation concurrent to immune checkpoint inhibition—particularly when it occurs early and extends beyond the radiation field—should prompt evaluation for immune-mediated bullous pemphigoid; ICI should generally be held for significant disease, while interruption of radiation should be individualized based on severity and in-field involvement. | Mann, Pract Radiat Oncol 2026
